Cognition Therapeutics Inc. Insider Trading
CGTX
Insiders bought 32K on the open market and sold nothing.
Get an email when CGTX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16 | John Brendan Doyle Chief Financial Officer | Bought | 10,000 | $1.13 | 11K | 1.6% | Form 4 |
| Apr 16 | Lisa Ricciardi CEO & President | Bought | 9,175 | $1.10 | 10K | 0.5% | Form 4 |
| Apr 16 | Anthony Caggiano Chief Medical Officer | Bought | 10,000 | $1.11 | 11K | 1.2% | Form 4 |
| Jan 31, 2025 | Lisa Ricciardi CEO & President | Bought | 38,851 | $0.77 | 30K | 4.3% | Form 4 |
- Apr 16John Brendan DoyleChief Financial Officer · bought 10,000 at $1.1311K1.6% of stake
- Apr 16Lisa RicciardiCEO & President · bought 9,175 at $1.1010K0.5% of stake
- Apr 16Anthony CaggianoChief Medical Officer · bought 10,000 at $1.1111K1.2% of stake
- Jan 31, 2025Lisa RicciardiCEO & President · bought 38,851 at $0.7730K4.3% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with CGTX
Held by ETFs
CGTX is in 2 US ETFs. The largest of them, with CGTX's weight in each:
Spot a number that looks wrong? Check it in CGTX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CGTX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.